Laduviglusib (GMP)
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-10182G-10MG | 10 mg | 1'356,00 | Add | |
| HY-10182G-50MG | 50 mg | 4'003,00 | Add | |
| HY-10182G-100MG | 100 mg | 6'347,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Laduviglusib (CHIR-99021) (GMP) is Laduviglusib (HY-10182) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Laduviglusib is a potent, orally active and selective GSK-3α/β inhibitor.
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | GMP |
| Research Field | Cancer, Metabolic Disease, Autophagy,PI3K/Akt/mTOR,Stem Cell/Wnt |
| Format | Solubility: 10 mM in DMSO |
| Grade | Clinical information: No Development Reported |
| Molecular Formula | C22H18Cl2N8 |
| Molecular Weight | 465.34 |
| CAS-Number | 252917-06-9 |
| Storage Conditions | -20°C (Powder, sealed storage, away from moisture and light) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Blue Ice |
| Material Safety Data Sheet | Download PDF |
